Skip to content

Upset Stomach Relief for Mild and Moderate Indigestion and Heartburn

Evaluation of the Impact of the HLNatural, Inc. Upset Stomach Relief Product on the Reduction of Symptoms in Adults Who Suffer From Mild to Moderate Indigestion and Heartburn

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04153552
Enrollment
161
Registered
2019-11-06
Start date
2019-10-16
Completion date
2020-08-18
Last updated
2021-11-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heartburn, Indigestion

Keywords

Natural, Supplement

Brief summary

The primary hypothesis of the present study is that supplementation with the Upset Stomach Relief test product will reduce the severity of the symptoms of occasional indigestion and heartburn.

Detailed description

The purpose of the present study is to evaluate 1) the impact of the test product on symptoms of occasional indigestion and heartburn in 200 adult participants who suffer from occasional indigestion and heartburn and 2) the subjective experience of these participants related to general health, indigestion and heartburn symptoms, and personal experience with the test product. While dietary and lifestyle changes can ease the symptoms of indigestion and heartburn, HLNatural, Inc. created the test product to reduce occasional indigestion and heartburn. The test product is a plant-based remedy formulated with ingredients that have demonstrated efficacy reducing symptoms associated with occasional indigestion and heartburn.

Interventions

DIETARY_SUPPLEMENTHLNatural, Inc. Upset Stomach Relief

Supplement to take with mild to moderate indigestion. The degree of your indigestion pre and post will be recorded

Sponsors

HLNatural, Inc.
CollaboratorINDUSTRY
Hawthorne Effect Inc.
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Intervention model description

The present study will be a single site, prospective, one arm observational study of minimal risk consisting of at least 200 participants who suffer from symptoms of occasional indigestion and heartburn. Participants will begin taking the capsules at the onset of indigestion and heartburn symptoms. Onset is defined as the point in time the participant takes the test product for relief of symptoms.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult candidates who are in overall good health but who suffer from the symptoms of indigestion. * Participants will be deemed to be in good health if they do not report any of the existing medical conditions asked about in the screening questionnaire.

Exclusion criteria

* Age \<18 years old. * Unwilling to take test product for their symptoms. * Are not able to swallow pills. * Allergy to any of the following: Licorice, Artichoke Leaf, Marshmallow Root, Ginger, Chamomile, Cellulose Capsule, Rice Hull Concentrate, Carrageenan. * Has any of the following medical conditions: * Has had an ulcer * Has been diagnosed with a digestive disorder * Diagnosed with gastroesophageal reflux disorder * Participants with diagnosed with irritable bowel syndrome * Participants with active HP infection or with gastric or duodenal ulcer * Participants who have been prescribed any medication by their physician for any GI disorder or medication that can affect the GI system. * Participants with previous diagnosis of cancer or with previous surgery of the upper gastrointestinal tract or of the biliopancreatic system (except for cholecystectomy) * Pregnant women or breastfeeding. * Alcohol consumption more than 7 drinks per week or more than 3 drinks per occasion * Participant who scores a 0, 3, or 4 on the Dyspepsia Symptom Severity Index * Participants who are currently using anticoagulation medications daily. (Aspirin, Coumadin, Heparin etc.)

Design outcomes

Primary

MeasureTime frameDescription
Outcomes of the severity and reduction of indigestion while consuming HLNatural Supplement.The improvements in symptoms will be evaluated from baseline.Participants will be asked to rate each symptom (bloating, early fullness during a meal, pain or discomfort in the upper abdomen, burning in the upper abdomen, pain/burning in the center of your chest, nausea, vomiting, and burping) on a 4-point scale at 4 time points. • At the onset of the indigestion and heartburn episode, the participant will start a Symptom Diary and complete a 4-point Likert scale for each of the symptoms they are experiencing.

Secondary

MeasureTime frameDescription
Outcomes of time to relief or to alternative treatment while taking HLNatural SupplementThe subject will write down symptoms in a diary and start of symptoms and again at 60 mins. The subject ill complete 4-point Likert Scale at start of event, 15 minutes, 30 minutes and 60 minutes after start of event.The participant is allowed to take alternative medications or supplements AFTER 1 hour from taking the test product. • If the participant takes any other medication outside of the test product, the participant will record this on the symptom diary.
Outcomes of all adverse events while consuming HLNatural SupplementAll adverse events will be captured throughout the trial which will be up to 60 days or 3 episodes of indigestion.Participants will be asked to report any adverse events that the subject experiences throughout the study.
Outcome of subjects natural behavior during the clinical trialThe time point will be evaluated from baseline to thoughout the trial up 60 days or 3 episodes of indigestion.At the start of the study participants will be asked to complete screening, baseline and demographic survey. At the completed of the study an exit study will be completed. This information along with what appears in the literature will help the investigators to better understand expected normal behavior of the participant.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026